July 8, 2020 / 11:35 AM / a month ago

BRIEF-Foghorn Therapeutics Announces Collaboration With Merck To Discover And Develop Novel Oncology Therapeutics Against Transcription Factor Target

July 8 (Reuters) - Merck & Co Inc:

* FOGHORN THERAPEUTICS ANNOUNCES COLLABORATION WITH MERCK TO DISCOVER AND DEVELOP NOVEL ONCOLOGY THERAPEUTICS AGAINST TRANSCRIPTION FACTOR TARGET

* FOGHORN THERAPEUTICS - WILL GRANT MERCK EXCLUSIVE RIGHTS TO DEVELOP & COMMERCIALIZE DRUGS THAT TARGET DYSREGULATION OF A SINGLE TRANSCRIPTION FACTOR

* FOGHORN THERAPEUTICS - TO RECEIVE UPFRONT PAYMENT & RESEARCH MILESTONES, WILL BE ELIGIBLE TO GET CERTAIN MILESTONES POTENTIALLY TOTALING UPTO $425 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below